Mr. Soliman is an independent non-executive director at Rameda Pharmaceuticals. He also currently sits on the boards of Ocyan-SA in Rio de Janeiro – Brazil, ADES Group, Exterran in Houston – USA and Energy and Mining Investments (EMI) based in Dubai. Mr. Soliman has 37 years of experience in engineering and management with Schlumberger. He has held multiple roles with the group including Senior Advisor to Schlumberger Global CEO, Executive President for the Middle East and Latin America. Executive president for Schlumberger Testing Services globally. He also previously served as President and Managing Director for Venezuela, Trinidad and the Caribbean and for Colombia, Peru, and Ecuador. In 2016 and 2017, he was recognized as one of the Middle East’s Top 100 Executives by Forbes Middle East. Mr. Soliman holds a Bachelor’s in Electrical Engineering from Helwan University.